US Stock MarketDetailed Quotes

LRMR Larimar Therapeutics

Watchlist
  • 6.170
  • +0.060+0.98%
Close Dec 13 16:00 ET
  • 6.290
  • +0.120+1.94%
Post 16:53 ET
393.69MMarket Cap-5.37P/E (TTM)

About Larimar Therapeutics Company

Larimar Therapeutics, Inc. Is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics mitochondrial disorders and Friedreich's ataxia. The company was founded in 2005 and is headquartered in Bala Cynwyd, PA.

Company Profile

SymbolLRMR
Company NameLarimar Therapeutics
Listing DateJun 19, 2014
Issue Price16.00
Founded2005
CEODr. Carole Ben-Maimon, M.D.
MarketNASDAQ
Employees42
Fiscal Year Ends12-31
Address3 Bala Plaza East,Suite 506
CityBala Cynwyd
ProvincePennsylvania
CountryUnited States of America
Zip Code19004
Phone1-844-511-9056
Websitehttp://larimartx.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Carole Ben-Maimon, M.D.
  • Director, President and Chief Executive Officer
  • 3.14M
  • Michael Celano
  • Chief Financial Officer and Principal Accounting Officer
  • 1.42M
  • Dr. Gopi Shankar, F.A.A.P.,M.B.A.,PhD
  • Chief Development Officer
  • 1.38M
  • Dr. Russell G. Clayton, D.O.
  • Chief Medical Officer
  • --
  • Joseph Truitt
  • Chairman of the Board
  • 114.96K
  • Frank E. Thomas
  • Independent Director
  • 86.21K
  • Dr. Jeffrey W. Sherman, F.A.C.P.,M.D.
  • Independent Director
  • 56.43K
  • Thomas Edward Hamilton
  • Independent Director
  • 77.77K
  • Jonathan S. Leff
  • Independent Director
  • 79.96K
Heat List
US
Overall
Symbol
Price
% Chg

No Data